Related Experiment Video
Updated: May 5, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Contemporary Diagnosis, Management, and Early Outcomes in Children with Kawasaki Disease in Romania: A Single-Center
Cristina Ramona Rădulescu1,2, Anca Cristina Drăgănescu1,2, Diana Maria Băncilă1,2
1Department of Pediatrics, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Insights
Kawasaki disease (KD) is a serious inflammatory condition in children. This study of Romanian children shows favorable outcomes with standard IVIG and aspirin treatment, with minimal cardiac complications.
Area of Science:
- Pediatrics
- Cardiology
- Rheumatology
Background:
- Kawasaki disease (KD) is an acute inflammatory vasculitis.
- It is a leading cause of acquired heart disease in children and young adults.
- Coronary artery complications are a significant concern in KD.
Purpose of the Study:
- To analyze the diagnostic process, therapeutic strategies, and early outcomes of Kawasaki disease in Romania.
- To present the largest contemporary Romanian cohort of KD patients.
- To evaluate cardiovascular complications and treatment responses.
Main Methods:
- Retrospective analysis of patients aged 0-18 years hospitalized between 2018-2023.
- Data collected on clinical presentation, treatment, and echocardiographic findings.
- Standard treatment protocols including intravenous immunoglobulin (IVIG) and acetylsalicylic acid were followed.
Main Results:
- 25 children diagnosed with KD; mean age 2.9 years, 56% boys.
- Fever ≥5 days and oral changes were most frequent symptoms.
- 100% received IVIG, 68% acetylsalicylic acid; 2 cases IVIG-resistant.
- Mild coronary artery dilatation (21.7%), mild valvular regurgitation, and small pericardial effusion noted.
- Infants showed less inflammation but higher leukocytosis and longer hospital stays.
- 92% discharged favorably, no deaths recorded.
Conclusions:
- This study represents the largest contemporary Romanian cohort of Kawasaki disease.
- Standard treatment protocols yielded favorable early outcomes with low rates of cardiac complications.
- The findings outline local diagnostic and therapeutic approaches for KD in Romania.
Abstract:
Background: Kawasaki disease (KD) is an acute inflammatory vasculitis with a particularly high incidence of coronary artery complications and constitutes a significant cause of acquired heart disease in children and young adults. Methods: We conducted a retrospective analysis of consecutive patients aged 0-18 years hospitalized at the "Prof. Dr. Matei Balş" National Institute of Infectious Diseases in Bucharest with Kawasaki disease over a period of 6 years (2018-2023). Results: A total of 25 children were discharged from hospital with this diagnosis during the analyzed period. The mean age was 2.9 years, and 56% were boys. Fever ≥5 days was present in all cases, and the most frequent additional sign was the presence of oral changes. Patients were treated according to in-effect guidelines with intravenous immunoglobulin (IVIG) (100%) and acetylsalicylic acid (68%). Only two cases were considered IVIG resistant and received a second IVIG infusion. Only mild cardiovascular changes were noted in echocardiography: mild coronary artery dilatation (21.7% of cases), mild valvular regurgitation, and small pericardial effusion. Infants displayed less inflammation and higher percentages of leukocytosis, developed an increase in platelet count sooner, received IVIG faster, and had longer hospital stays. Outcomes were generally favorable, and 92% of children were discharged, while the two remaining patients were transferred to other centers. No deaths were recorded. Conclusions: To our knowledge, this is the largest contemporary Romanian cohort of Kawasaki disease published to date, outlining the local diagnostic process, therapeutic strategies, and early outcomes of Kawasaki disease.
Related Concept Videos
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management

